Preliminary results from a clinical trial of remdesivir, an experimental antiviral drug being tested for coronavirus, could come in as little as one to two weeks, a top researcher said Sunday.
The final results aren’t expected until mid-to-late May, said Dr. Andre Kalil, a principal investigator for the trial. But he said “we can potentially have some early data in the next one or two weeks,” contingent on a preliminary analysis.
“In the next few weeks, we’re going to do the analysis, and we’re going to basically know if remdesivir is better or not than placebo,” he told CNN.
Comments are closed.